Skip to main content

Advertisement

ADVERTISEMENT

Volume 14 - Issue 12 - December, 2002

Column

Editorial Message
08/01/2008
Richard E. Shaw, PhD, FACC, Editor-in-Chief
Richard E. Shaw, PhD, FACC, Editor-in...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, an editorial, brief reviews, the session V discussion from this year’s International Andreas Gruentzig Society Meeting,...
Dear Readers, This issue of the Journal of Invasive Cardiology includes original research articles, case reports, an editorial, brief reviews, the session V discussion from this year’s International Andreas Gruentzig Society Meeting,...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology

News

Teaching Collection
08/01/2008
George W. Vetrovec, MD
George W. Vetrovec, MD
Introduction. Coronary intervention has made remarkable advances over the past 25 years. Technical advancements have markedly improved immediate procedure safety and success. With the advent of drug-eluting stents, opportunities for even...
Introduction. Coronary intervention has made remarkable advances over the past 25 years. Technical advancements have markedly improved immediate procedure safety and success. With the advent of drug-eluting stents, opportunities for even...
Introduction. Coronary...
08/01/2008
Journal of Invasive Cardiology

Feature

Case Report
08/01/2008
Alexandre C. Ferreira, MD, Darwin Eton, MD, Eduardo de Marchena, MD
Alexandre C. Ferreira, MD, Darwin Eto...
Vascular complications requiring surgical repair have been described in approximately 1% of patients after coronary intervention. Despite availability of multiple closure devices, this vexing problem is yet to be resolved. Approximately...
Vascular complications requiring surgical repair have been described in approximately 1% of patients after coronary intervention. Despite availability of multiple closure devices, this vexing problem is yet to be resolved. Approximately...
Vascular complications requiring...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Madhavagopal Cherukuri, MD and Ashish Pershad, MD
Madhavagopal Cherukuri, MD and Ashish...
The use of glycoprotein IIb/ IIIa antagonists in the cardiac catheterization laboratory has continued to increase. These agents, however, have been associated with an increase in both minor and major bleeding complications.1,2 Such...
The use of glycoprotein IIb/ IIIa antagonists in the cardiac catheterization laboratory has continued to increase. These agents, however, have been associated with an increase in both minor and major bleeding complications.1,2 Such...
The use of glycoprotein IIb/...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
A.H. Sami Aldoboni, MD, E. Amir Hamza, MD, K. Majdi, MD, M. Ngibzadhe, MD, S. Palasaidi, MD, D. Akhlag Moayed, MD
A.H. Sami Aldoboni, MD, E. Amir Hamza...
Non-atherosclerotic causes of myocardial infarction should be considered in patients with no coronary artery disease risk factors. These causes include arterial emboli, severe prolonged coronary artery spasm, traumatic or spontaneous...
Non-atherosclerotic causes of myocardial infarction should be considered in patients with no coronary artery disease risk factors. These causes include arterial emboli, severe prolonged coronary artery spasm, traumatic or spontaneous...
Non-atherosclerotic causes of...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Octavia Balan, MD, Yoshio Kobayashi, MD, Jeffrey W. Moses, MD
Octavia Balan, MD, Yoshio Kobayashi, ...
Since randomized studies showed a lower restenosis rate in focal coronary artery lesions with coronary stenting compared to conventional balloon angioplasty,1 indications for stenting expanded to complex lesions such as bifurcation and...
Since randomized studies showed a lower restenosis rate in focal coronary artery lesions with coronary stenting compared to conventional balloon angioplasty,1 indications for stenting expanded to complex lesions such as bifurcation and...
Since randomized studies showed...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
08/01/2008
Moderator: James P. Zidar Panel Members: Hall Whitworth; Peter Gonschior; Stefan Beyer-Enke; Luis de la Fuente
Moderator: James P. Zidar Panel Membe...
NULL
NULL
NULL
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Current Status of Antithrombotics and Antiplatelets in PCI A. Michael Lincoff, MD Dr. Michael Lincoff stated that despite the advent of stents, which are clearly effective in reducing restenosis, we continue to have ischemic complications...
Current Status of Antithrombotics and Antiplatelets in PCI A. Michael Lincoff, MD Dr. Michael Lincoff stated that despite the advent of stents, which are clearly effective in reducing restenosis, we continue to have ischemic complications...
Current Status of...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Moderator: James P. Zidar Panel Members: Hall Whitworth; Peter Gonschior; Stefan Beyer-Enke; Luis de la Fuente
Moderator: James P. Zidar Panel Membe...
Hall Whitworth: We have performed about 350 cases at our center and it has evolved somewhat over the last couple of years. Initially, we used the CheckMate system because of its greater length. The pullback and stepping techniques have...
Hall Whitworth: We have performed about 350 cases at our center and it has evolved somewhat over the last couple of years. Initially, we used the CheckMate system because of its greater length. The pullback and stepping techniques have...
Hall Whitworth: We have...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Moderator: James P. Zidar Panel Members: Hall Whitworth; Peter Gonschior; Stefan Beyer-Enke; Luis de la Fuente
Moderator: James P. Zidar Panel Membe...
Hall Whitworth: There is another subset of patients who will be asking for these new drug-coated stents: those with long, diffuse distal disease. We may decide to treat such patients medically, but they too will be clamoring for the new...
Hall Whitworth: There is another subset of patients who will be asking for these new drug-coated stents: those with long, diffuse distal disease. We may decide to treat such patients medically, but they too will be clamoring for the new...
Hall Whitworth: There is another...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement